Robuta

https://www.ncbi.nlm.nih.gov/Structure/pdb/5BZD
5G8 HIV Antibody heavy chain5G8 HIV Antibody light chainGLYCEROL
crystal structurefrom theantibody
https://pubmed.ncbi.nlm.nih.gov/22345481/
Recently, several broadly neutralizing monoclonal antibodies (bnMAbs) directed to the CD4-binding site (CD4bs) of gp120 have been isolated from HIV-1-positive...
binding sitehivantibody
https://www.jci.org/articles/view/126391/citations
jcicitationsantibodyfceffector
https://www.ncbi.nlm.nih.gov/Structure/pdb/3D0L
2F5 heavy chain2F5 light chainHyb3k peptide constructGLYCEROLSULFATE ION
broadly neutralizing antibodycrystal structurethe hiv
https://www.sciencedaily.com/releases/2018/05/180507111840.htm
Scientists have invented a universal antibody drug against HIV/AIDS. By engineering a tandem bi-specific broadly neutralizing antibody, the team found that...
universalantibodydrughivprevention
https://www.ncbi.nlm.nih.gov/Structure/pdb/6P3B
DH501UCA Fab Heavy chainDH501UCA Fab Light chain1,2-ETHANEDIOL
crystal structurehiv antibody
https://elifesciences.org/articles/63444
HIV-specific antibodies that mediate antibody-dependent cellular cytotoxicity vary in their paths to achieve function but commonly rely on mutations in...
developmentantibodydependentcellcytotoxicity
https://pubmed.ncbi.nlm.nih.gov/29768174/
HIV-1 vaccine development has been stymied by an inability to induce broadly reactive neutralizing antibodies to the envelope (Env) trimer, the sole viral...
b cellhivvaccinesbasedantibody
https://www.mdpi.com/2076-393X/9/3/260
The antibodies with different effector functions evoked by Human Immunodeficiency Virus type 1 (HIV-1) transmitted from mother to child, and their role in the...
continuoushivescapeautologousneutralization